Evaluating the Effects of Kombucha as a Hyperglycemic Therapeutic Agent Within Diabetic Human Subjects

Last updated: July 28, 2020
Sponsor: Georgetown University
Overall Status: Completed

Phase

N/A

Condition

Diabetes Prevention

Diabetes And Hypertension

Treatment

N/A

Clinical Study ID

NCT04107207
STUDY00001101
  • Ages > 18
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

This study's primary objective is to determine the ability of Kombucha to impact blood sugar levels in patients with diabetes mellitus type II. The secondary objective is to determine the ability of Kombucha to impact blood pressure, and quality of life measures as measured by uniform questionnaire that includes: gut health, colds, infections, headaches, sleep, anxiety (GAD2), depression (PHQ2), skin health.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. S/he is above the age of 18

  2. S/he has the ability to read, speak and write English

  3. S/he has telephone access

  4. S/he is diabetic and willing to check blood sugar levels every day

  5. Hb A1c >7%

  6. Possesses a glucometer

Exclusion

Exclusion Criteria:

  1. Allergy to kombucha ingredients

  2. Drinks kombucha regularly (>3time per week)

Study Design

Total Participants: 12
Study Start date:
November 11, 2019
Estimated Completion Date:
July 01, 2020

Connect with a study center

  • Georgetown University MedStar Hospital

    Washington, District of Columbia 20007
    United States

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.